REGN

Nasdaq

REGENERON PHARMACEUTICALS, INC.

Health Care, Biotechnology

$784.36

close 7 Aug 2026

+43.67%

52-week change

$80.75B

market cap

$541.00

$821.11

52-week range

Expected price

$640.30 – $782.59

Current price

$784.36

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)19.42x

P/S (TTM)5.20x

P/B2.55x

EV/EBITDA (TTM)18.36x

FCF yield (TTM)4.66%

PEG (TTM, GAAP)7.02

Context

P/E, own 5-year average17.91x

P/E, sector median29.65x*

Price at 5-year median P/E$700.98*

Indicated dividend yield0.48%

Forward — analyst consensus

Forward P/E (FY2026)14.80x*

Forward P/E (FY2027)15.56x

Forward PEG—*

Consensus EPS FY2026 (28 analysts)$53.00

EPS growth (FY2026→FY2027)-4.91%

Revenue growth (FY2026)17.75%

Street view

Price target (mean)$833.54*

Target upside6.27%

Ratings (buy / hold / sell)18 / 9 / 0

FY2026 EPS revisions, 30d (up / down)2 / 16

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 30 Jul 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +15.29%10Y CAGR +20.11%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$784.36

Cash & equivalents$2.46B

Total debt$1.99B

Shares outstanding102.95M

Result

DCF price per share$1,845.00

Current price$784.36

Margin of safety+135.22%

PV of years 1–10$54.81B

PV of terminal value$134.67B

Equity value$189.95B

Market-implied growth+4.24%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$4.34B	$5.00B	$5.76B	$6.64B	$7.66B	$8.83B	$10.18B	$11.74B	$13.53B	$15.60B	$290.74B
PV	$4.01B	$4.29B	$4.57B	$4.88B	$5.21B	$5.56B	$5.94B	$6.34B	$6.77B	$7.23B	$134.67B

period to 30 Jun 2026, filed 30 Jul 2026, close 7 Aug 2026